-
Forward Look
Advances in Treating Non–Small Cell Lung CancerExpanded approvals in 2016 increase options.
by Jennifer L.W. Fink
-
Forward Look
Cancer Cells Can Change as They Grow and SpreadStudies suggest metastases may respond to different drugs than the primary tumor.
by Chris Palmer
-
A Prescription for Prevention?
Scientists are working to understand the molecular processes that transform normal cells into cancer cells in the hope they can prevent the disease before it starts.
by Marci A. Landsmann
-
Seeking a Second Opinion
Another perspective on your disease may help you find the best cancer care.
by Stephen Ornes
-
Healthy Habits
Tanning TroubleIndoor tanning is a major culprit in melanoma diagnosed early in life.
by Kate Yandell
-
From the Editor-in-Chief
Cancer and the MicrobiomeAltering the gut microbiota and microbiome could become a strategy for cancer prevention and treatment.
by William G. Nelson, MD, PhD
-
Forward Look
What Is CRISPR?Q&A with oncologist Howard Kaufman on the new gene-editing tool.
by Chris Palmer
-
Forward Look
Longer Treatment May Benefit Some Breast Cancer PatientsTen years of hormone therapy studied.
by Sue Rochman
-
Forward Look
Addressing Depression in Adult Cancer SurvivorsStudy links depression to money woes and missed opportunities for follow-up.
by Marilyn Fenichel
Cancer Talk
Declining Breast Cancer Mortality in Younger Women
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin